Dr. Kay Yeung, MD

Dr. Yeung practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Yeung's NPI, 1215285770, was assigned on August 15, 2012. Dr. Yeung graduated from New York University School of Medicine in 2012. Dr. Yeung holds California license A126847.

Dr. Yeung's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Yeung's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Yeung is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yeung practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Yeung's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Yeung is board certified in hematology by the American Board of Internal Medicine. Dr. Yeung is licensed in California.

Dmand AI lists breast cancer among the conditions Dr. Yeung treats.

CMS data shows 472 Medicare services from Dr. Yeung across 4 procedure codes in 2024, for 131 Medicare patients. Medicare paid $26,691 for them.

CMS counts 131 Medicare patients who saw Dr. Yeung in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have cancer, and 69% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yeung's median patient age at 60, with 96% women.

In 2024, Dr. Yeung wrote 609 Medicare Part D claims for 105 patients. 63% of them were for generic drugs. CMS names the drug for 412 of them, across 11 drugs with 11 or more claims each, at $2,543,929 in total drug cost. In 2023, CMS named 361 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Yeung for performance year 2024, reported as part of a group. Dr. Yeung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yeung as offering telehealth.

Dmand AI links 14 papers to Dr. Yeung, published from 2011 to 2024. 2024 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Antineoplastic Agents and Cell Line, Tumor. Dr. Yeung has published most often in Nat Med. Dr. Yeung's most frequent co-authors are Anthony Elias, MD, Barbara A. Parker, MD and Erica Stringer-Reasor.

Dmand AI links Dr. Yeung to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 8 general payments to Dr. Yeung from 5 drug and device companies from 2019 to 2025. Grants make up the largest share, 40% of the total. AstraZeneca Pharmaceuticals LP paid the most, $350. It also lists 1 research payment totaling $11,570 in 2022.

Dr. Yeung graduated from New York University School of Medicine in 2012. Dr. Yeung is a member of AACR and ASCO.

Dr. Yeung is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.